646 related articles for article (PubMed ID: 12107916)
21. Pathophysiology, diagnosis and treatment of ascites in cirrhosis.
Arroyo V
Ann Hepatol; 2002; 1(2):72-9. PubMed ID: 15115971
[TBL] [Abstract][Full Text] [Related]
22. Ascites: diagnosis and management.
Hou W; Sanyal AJ
Med Clin North Am; 2009 Jul; 93(4):801-17, vii. PubMed ID: 19577115
[TBL] [Abstract][Full Text] [Related]
23. Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome.
Arroyo V; Terra C; Ginès P
J Hepatol; 2007 May; 46(5):935-46. PubMed ID: 17391801
[No Abstract] [Full Text] [Related]
24. Management of ascites in patients with end-stage liver disease.
Saadeh S; Davis GL
Rev Gastroenterol Disord; 2004; 4(4):175-85. PubMed ID: 15580152
[TBL] [Abstract][Full Text] [Related]
25. Pathophysiology and treatment of ascites and the hepatorenal syndrome.
Gentilini P; Laffi G
Baillieres Clin Gastroenterol; 1992 Sep; 6(3):581-607. PubMed ID: 1421601
[TBL] [Abstract][Full Text] [Related]
26. Pathogenesis and management of the hepatorenal syndrome.
Laffi G; La Villa G; Gentilini P
Semin Liver Dis; 1994 Feb; 14(1):71-81. PubMed ID: 8016664
[No Abstract] [Full Text] [Related]
27. [Hepatorenal syndrome: diagnosis, treatment and prevention].
Egerod Israelsen M; Gluud LL; Bendtsen F; Møller S; Krag AA
Ugeskr Laeger; 2013 May; 175(22):1562-6. PubMed ID: 23721840
[TBL] [Abstract][Full Text] [Related]
28. Hepatorenal syndrome: definition, pathophysiology, clinical features and management.
Bataller R; Sort P; Ginès P; Arroyo V
Kidney Int Suppl; 1998 May; 66():S47-53. PubMed ID: 9573573
[No Abstract] [Full Text] [Related]
29. Hepatorenal syndrome.
Bataller R; Arroyo V; Ginès P; Sort P
Forum (Genova); 1998; 8(1):62-81. PubMed ID: 9565447
[TBL] [Abstract][Full Text] [Related]
30. Review article: Management of ascites and associated complications in patients with cirrhosis.
Kuiper JJ; de Man RA; van Buuren HR
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():183-93. PubMed ID: 18081661
[TBL] [Abstract][Full Text] [Related]
31. Minimizing ascites. Complication of cirrhosis signals clinical deterioration.
Garcia N; Sanyal AJ
Postgrad Med; 2001 Feb; 109(2):91-6, 101-3. PubMed ID: 11272697
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of ascites, hyponatremia and hepatorenal syndrome in liver cirrhosis].
Ackermann D
Ther Umsch; 2009 Nov; 66(11):747-51. PubMed ID: 19885792
[TBL] [Abstract][Full Text] [Related]
33. Management of refractory ascites and hepatorenal syndrome.
Sussman AN; Boyer TD
Curr Gastroenterol Rep; 2011 Feb; 13(1):17-25. PubMed ID: 21080246
[TBL] [Abstract][Full Text] [Related]
34. [Therapy of the hepatorenal syndrome].
Laffi G; Gentilini P
Minerva Med; 1987 May; 78(10):669-74. PubMed ID: 3295597
[No Abstract] [Full Text] [Related]
35. Management of ascites in cirrhosis.
Sandhu BS; Sanyal AJ
Clin Liver Dis; 2005 Nov; 9(4):715-32, viii. PubMed ID: 16207572
[TBL] [Abstract][Full Text] [Related]
36. Management of ascites in patients with liver cirrhosis: recent evidence and controversies.
Hsu SJ; Huang HC
J Chin Med Assoc; 2013 Mar; 76(3):123-30. PubMed ID: 23497963
[TBL] [Abstract][Full Text] [Related]
37. [Hepatorenal syndrome].
Pillebout E
Nephrol Ther; 2014 Feb; 10(1):61-8. PubMed ID: 24388293
[TBL] [Abstract][Full Text] [Related]
38. Targeting circulatory dysfunction in cirrhosis: terlipressin and the hepatorenal syndrome.
Testro AG; Angus PW
J Gastroenterol Hepatol; 2009 Nov; 24(11):1707-9. PubMed ID: 20136956
[No Abstract] [Full Text] [Related]
39. [Therapy of hepatorenal syndrome].
Walter E
Praxis (Bern 1994); 1997 Jan; 86(4):102-3. PubMed ID: 9064719
[TBL] [Abstract][Full Text] [Related]
40. Current management of the complications of portal hypertension: variceal bleeding and ascites.
Dib N; Oberti F; Calès P
CMAJ; 2006 May; 174(10):1433-43. PubMed ID: 16682712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
